Featured Events!

Process Validation Summit 2017

May 18-19, 2017, Philadelphia, PA

Are you compliant with FDA requirements for process validation? This two-day intensive summit brings together industry leaders to help you exceed regulatory thresholds and avoid costly FDA inspection findings.

With Representation From:

  • FDA
  • Abbott
  • Bayer
  • Genzyme
  • GSK
  • QPharma
  • Patheon
  • Pfizer
  • Arlenda
  • Snee Associates
  • PharmaTech Associates
  • Compliance Team Inc
  • ResMedica
  • Stat4Ward
  • Takeda
  • BergumSTATS
  • TARIS Biomedical
  • Tunnell Consult

Featuring Comprehensive Coverage On:

  • FDA Process Validation and Risk Management Approaches
  • Lifecycle Approach to Process Validation
  • Global Technology Transfer and Process Validation
  • Achieving the Business and Compliance Benefits of Quality by Design (QbD) and Continued Process Verification (CPV)
  • Legacy Products - From Retrospective to Prospective Process Validation
  • Validation Sampling Plans and Statistical Process Control
  • Cost-effective Process Validation Lifecycle Management
  • Implementing a Comprehensive Strategy for Process Validation: Stage 3, Continued Process Verification
  • Establishing a Continuum of Criticality for Process Parameters and Quality Attributes Throughout the Lifecycle
  • Process Control Strategy and Process Performance Qualification of a Drug/Device Combination Product
  • The Drug Supply Chain Security Act-How Does it Relate to Validation?
  • And Much More!

Event Sponsors:

Transdermal and Intradermal Drug Delivery Systems, 2017

Advanced Design, Development, and Delivery of Skin-Mediated Therapies and Vaccines

September 28-29, 2017, Racquet Club of Philadelphia, PA

The growing interest in alternative routes of drug administration has experts predicting that the market for transdermal and intradermal drug delivery systems will exceed $25 billion by 2018. The industry is on the threshold of bringing into commercial production a new generation of transformative TDD and IDD therapies and delivery systems. That is why you cannot afford to miss this two-day intensive conference. Pharma Ed brings together leading researchers in the field to share the most recent advances in the design, formulation, and delivery of skin-mediated therapies and vaccines.

Featuring Representation From:

  • Pfizer
  • Merck
  • Corium
  • 3M
  • Tapemark
  • MIT
  • UCSB
  • Queens University, Belfast
  • Georgia Tech
  • Texas Tech
  • Ole Miss
  • University of Cincinnati
  • Mercer University
  • University of Maryland
  • QPS
  • Solaris Pharma
  • Intertek
  • Eurofins Lancaster Labs
  • ISYN Consulting

With Comprehensive Coverage on:

  • Improving Bioavailability Via Transdermal Administration
  • Latest Advances in Microneedle Drug and Vaccine Delivery
  • How to Move from Passive to Active Skin-Mediated Delivery Technologies for Drugs and Biologics
  • Optimizing TDD & IDD for Efficacious Delivery and Patient Compliance
  • Mechanisms of Dermal and Transdermal Absorption of Drugs
  • Computational Modeling of Transdermal and Intradermal Delivery
  • Resolving Regulatory Compliance Issues for TDD & IDD Systems
  • IVPT and IVRT of Transdermal and Topical Products
  • Exploring the Promise of Ionic Liquids for Transdermal Applications
  • And much more!

Spring Special: Register by May 15th and Receive $300 Off the Standard Rate!!

Event Sponsor:

Media Partner:

Extractables, Leachables, & Elemental Impurities 2017 - West Coast

Ensuring Quality, Safety, and Regulatory Compliance for Drugs & Biologics

October 24-25, Sheraton La Jolla

Attention to leachables, extractables, and elemental impurities has increased due to the recent revisions of USP and ICH guidelines, as well as the upcoming revisions to three major ISO 10993 standards. This two-day conference will examine the safety, quality, and regulatory issues involved in a wide array of contexts central to the pharmaceutical industry, including drug packaging and delivery components, single-use systems, and parenteral drug products. We will hear from key industry working groups such as PQRI and BPOG. In addition, we will focus closely on the keys to satisfying recent ICH and USP guidelines for metal impurities in current and future drug products and biologics.

With Representation From:

  • Pfizer
  • Allergan
  • Amgen
  • Janssen
  • Lilly
  • Sanofi
  • Shire
  • Aspen Research
  • Pall
  • Jordi Labs
  • Eurofins
  • West Pharmaceutical Services
  • Agilent
  • Amri Global
  • VR Analytical
  • Material Needs Consulting
  • Triad
  • Eakins & Associates
  • Knoell

Featuring Comprehensive Coverage On:

  • Updates & Case Studies on the Latest Compliance Implications of USP and ICH Q3D Risk Assessment Filing Guidelines for Elemental Impurities
  • The Risk Assessment of Extractables - A Toxicological Window of Opportunity
  • BPOG's Leachables Best Practice Guide: Study Design and Analytical Methods
  • Challenges & Consequences for the Medical Device Industry by the Revision of Three Major ISO 10993 - Standards
  • Extractables Screening of Polyproylene Resins for the Identification of Suitability for Use Hazards
  • Maximizing E/L Studies Through Harmonization of USP & ISO 10993
  • Leachable Risk Assessment of Dosing Devices for Parenteral Applications
  • Extractables & Leachables Studies on Single-Use Components in Biomanufacturing
  • Addressing Challenges with Polysorbate 80
  • E&L Test Methodologies for Lyophilized Drug Products
  • Industry Working Group Updates: PQRI & BPOG
  • And More!

Early Bird Special: Register by August 1st and Receive a $200 Discount!


Extractables & Leachables Practical Workshop

How to Apply USP Requirements to Design and Execute Extractable and Leachable Studies

September 27, 2017, Racquet Club of Philadelphia, PA

The workshop will discuss different analytical approaches related to extractable and leachable testing. Practical recommendations will be presented for designing and executing controlled ex- tractions. Analytical solutions will be explained according to the latest regulatory expectations. The workshop will provide practical guidance and case studies from start to completion.

Upcoming Events

Lyophilization Forum, October 4-5, 2017

Philadelphia, PA

Cleaning Validation Summit, October 2-3, 2017

Philadelphia, PA

Why PharmaEd?

Profitable Networking

Industry innovators and established professionals meet to share ideas, forge relationships, and imagine new opportunities.

Experience You Trust

Our team has over four decades of combined experience producing conferences and delivering real value to the pharma industry.

An Industry Leader

Pharma Ed has collaborated with over 250 companies and organizations to produce some of the most informative meetings in the industry.

Our Mission

To deliver the most current, market-driven information to meet your research, product development, regulatory, quality assurance, and technical needs.

Relevant Training

Cutting-edge knowledge drawn from top pharmaceutical, biotech, and academic experts.

Sponsorship Opportunities!

Sponsor a PharmaEd event and set your business apart!


What People Are Saying About
Pharma Ed Events

"A Fantastic meeting. I was interested in so many of the talks and I met several clients - current and potential."
- Principal Scientist, Aptuit SSCI

"I really enjoyed the meeting... Stronger speakers and more in depth coverage than some of the others on the market."
- Director, Emerson Resources, Inc.

"Thank you again for such an excellent program - it was very informative and enjoyable."
- Sr. Principal Scientist, Bausch + Lomb

"I go to a lot of conferences, and this was an excellent one."
- Sr. Scientist, Boehringer Ingelheim

"Great audience, with good choice of speakers. Would love to attend again."
- Principal Scientist, Pfizer

"I greatly enjoyed the conference. I found the topics relevant and containing great content. I look forward to bringing the knowledge and principles to my role in R&D."
- Manager, CSL Behring

"I was very pleased with the material presented, and the expertise of the presenters. I will be taking much valuable/applicable knowledge back to my company."
- QA Director, Biothera

"Each and every presentation contained information that I found to be useful and relevant and many presentations left me with ideas and concepts that I look forward to considering in greater detail."
- Distinguished Scientist, Baxter

"The presentations & experience of the presenters was very instructive & helpful toward building my programs."
- QA/Corporate Director, Medicago, Inc.

"This is a valuable conference, with many expert speakers."
- Product Manager, EMD Millipore

"I really enjoyed it. I feel engaged and like there is a lot to learn."
- Assoc. Scientist, Bristol-Myers Squibb

"Very good conference with knowledgeable presenters, good feedback, and 'real world' examples/takeaways."
- Assoc. Director of PV, Shire

"Great mix of topics and excellent networking sessions."
- Deputy Director, Sanofi Pasteur

"Very useful conference for us. Learned a lot from all the presentations."
- Scientist I, Amneal Pharmaceuticals

"I am new to the med device E/L scene, so I attended as a learning opportunity and to begin to get up to speed. I feel the conference was very informative and balanced various subject areas as well. I'll definitely plan on attending again."
- Research Toxicologist, NSF International